Acutis Biosciences

Acutis Diagnostics is a commercial-stage, revenue-generating clinical laboratory specializing in high-complexity molecular diagnostics and toxicology testing. The company leverages PCR technology, automation, robotics, and AI-driven algorithms to deliver rapid, accurate results with industry-leading turnaround times, primarily serving healthcare providers and biopharma clients. Its core business is divided into patient testing services and research solutions, positioning it at the intersection of clinical diagnostics and biopharma support services. With over 3 million samples processed and accreditations including CLEP (NYSDOH), Acutis emphasizes compliance, scientific rigor, and customer service.

Utilizes PCR, automation, robotics, and AI-driven algorithms for high-throughput, rapid clinical diagnostic testing and toxicology analysis. Focus is on operational efficiency and data delivery rather than a proprietary therapeutic platform.

Acutis competes in the fragmented clinical laboratory market against national leaders like Quest Diagnostics and Laboratory Corporation of America (LabCorp), as well as regional labs and specialized toxicology/diagnostic providers. Its differentiation is based on specialized test menus (e.g., novel toxicology), rapid turnaround times, customer service, and technological integration (AI/automation), rather than scale.